Trial Profile
An Australian Imaging Biomarkers and Lifestyle-Veterans Study (AIBL-VETS) using β-Amyloid and Tau Imaging in Obstructive Sleep Apnoea
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2017
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary) ; Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms AIBL-VETS
- 29 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017